Candida auris is an emerging multi-drug resistant yeast, that causes major issues regarding
patient treatment and surface disinfection in hospitals. Indeed, an important proportion of C …

Candida auris and Candida albicans can result in invasive fungal diseases. And yet, these
species can stably and asymptomatically colonize human skin and gastrointestinal tracts. To …

Candida auris recently emerged as an urgent public health threat, causing outbreaks of
invasive infections in healthcare settings throughout the world. This fungal pathogen persists …

Background Candida auris is a new pathogen called “superbug fungus” which caused panic
worldwide. There are no large-scale epidemiology studies by now, therefore a systematic …

Background Increased hospitalisation rates in the Coronavirus disease 19 (COVID‐19) era
lead to a new wave of hospital‐acquired infections such as emerging multidrug‐resistant …

Abstract Purpose of Review Emergent fungal pathogen C. auris is spreading in hospitals
throughout the world and mortality rates for patients with invasive disease approach 60 …

Candida auris, a newly emerging healthcare-associated yeast pathogen from the
Metschnikowiaceae family, was first described in the ear canal of an elderly Japanese …

Background Candida auris is an emerging multidrug‐resistant pathogen in intensive care
settings (ICU). During the coronavirus disease 19 (COVID‐19) pandemic, ICU admissions …

Abstract The World Health Organization (WHO) in 2022 developed a fungal priority
pathogen list. Candida auris was ultimately ranked as a critical priority pathogen. PubMed …

Key Points Candida auris Infections Since 2009, when it was first identified, Candida auris
has rapidly spread across more than 45 countries in six continents; it has been subdivided …